Jash, Sukanta
Banerjee, Sayani
Cheng, Shibin http://orcid.org/0000-0003-4911-6234
Wang, Bin http://orcid.org/0000-0001-9032-5009
Qiu, Chenxi
Kondo, Asami
Ernerudh, Jan http://orcid.org/0000-0001-9456-2044
Zhou, Xiao Zhen http://orcid.org/0009-0002-7849-2116
Lu, Kun Ping http://orcid.org/0000-0002-0734-1567
Sharma, Surendra http://orcid.org/0000-0002-4331-3467
Funding for this research was provided by:
Canada Foundation for Innovation (43822)
U.S. Department of Health & Human Services | National Institutes of Health (P20 GM121298, P30 GM114750, R01CA205153, R01AG055559, 3P20GM121298-04W1, P30 GM114750)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (3P20GM121298-04W1)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 25 July 2022
Accepted: 24 August 2023
First Online: 5 September 2023
Competing interests
: X.Z.Z. and K.P.L. are inventors of issued patents and/or pending patent applications including on <i>cis</i> and <i>trans</i> P-tau antibodies and the scientific founders and former scientific advisors of and own equity in Pinteon. The other authors declare no competing interests.